NASDAQ: KERX Investor Alert: Lawsuit Filed Against Acquisition by Keryx Biopharmaceuticals, Inc.
An investor, who currently holds shares of Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX), filed a lawsuit against the takeover of Keryx Biopharmaceuticals, Inc.
View full press release